mandana kazemi

Dr. mandana kazemi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2021 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
JEJohann Ebadfardzadeh
Johann Ebadfardzadeh
mandana kazemimandana kazemi
mandana kazemi
AAAli Aghazadeh
Ali Aghazadeh
MRMonireh Rezaei
Monireh Rezaei
Milad ShirvalilooMilad Shirvaliloo
Milad Shirvaliloo
RSRoghayeh Sheervalilou
Roghayeh Sheervalilou


20 March 2024 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
ZMZeinab Moradi
Zeinab Moradi
mandana kazemimandana kazemi
mandana kazemi
RJRoya Jamshidi-Khalifelou
Roya Jamshidi-Khalifelou
VBVahid Bahramnia
Vahid Bahramnia
FEFatemeh Esfandmaz
Fatemeh Esfandmaz
TGTohid Piri gharaghie
Tohid Piri gharaghie

1 December 2021 in Gene Reports
Verified
Journal Article
Closed access
mandana kazemimandana kazemi
mandana kazemi
MPMaryam Peymani
Maryam Peymani

5 March 2025 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
mandana kazemimandana kazemi
mandana kazemi
MPMaryam Peymani
Maryam Peymani
MBMehrdad Behmanesh
Mehrdad Behmanesh
RGRazieh Ghasemi
Razieh Ghasemi

27 March 2025 in Medical Journal of Indonesia
Verified
Journal Article
Open access
PDF file
SKSeyedeh Mahdieh Khoshnazar
Seyedeh Mahdieh Khoshnazar
mandana kazemimandana kazemi
mandana kazemi
PJParnian Jahanbani
Parnian Jahanbani
MAMohammad Reza Moghare Abed
Mohammad Reza Moghare Abed
SAShamim Afshoon
Shamim Afshoon
BACKGROUND Breast cancer is a major global health challenge, with diverse and complex gene expression profiles. Long noncoding RNAs (lncRNAs) have emerged as key regulators of various cancers, including breast cancer. This study aimed to investigate the expression and prognostic value of dual specificity phosphatase 1 (DUSP1), LINC02202, and LINC01554 in breast cancer tissues and explore their association with clinical parameters. METHODS DUSP1, LINC02202, and LINC01554 expression in healthy and breast tumor tissues were compared using in vitro and in silico conditions. In silico conditions examined their association with patient survival and disease prognosis through Kaplan−Meier and receiver operating characteristic curves. In vitro conditions examined the association between their expression and clinical parameters, such as tumor size, disease stage, and disease prognosis. RESULTS Our study found that DUSP1, LINC02202, and LINC01554 were significantly downregulated in breast tumor tissues compared to healthy tissues, as shown by both in vitro and in silico analyses. Their expression levels are also significantly associated with the prognosis of breast cancer. Notably, only LINC02202 expression was significantly correlated with reduced patient survival and tumor size. CONCLUSIONS This study provides novel insights into the expression and function of DUSP1 mRNA, LINC02202, and LINC01554 lncRNAs in breast cancer and identifies potential biomarkers and therapeutic targets for this disease.